172 related articles for article (PubMed ID: 3711257)
1. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
Williams TD; Dunger DB; Lyon CC; Lewis RJ; Taylor F; Lightman SL
J Clin Endocrinol Metab; 1986 Jul; 63(1):129-32. PubMed ID: 3711257
[TBL] [Abstract][Full Text] [Related]
2. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
4. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
6. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
7. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
Moses AM; Scheinman SJ; Schroeder ET
Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
Kinter LB; Beeuwkes R
Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
[TBL] [Abstract][Full Text] [Related]
10. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
11. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
[TBL] [Abstract][Full Text] [Related]
12. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
Fjellestad A; Czernichow P
Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
[TBL] [Abstract][Full Text] [Related]
13. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
Vilhardt H; Bie P
Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
[TBL] [Abstract][Full Text] [Related]
14. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
Czakó L; Julesz J; László FA
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
[TBL] [Abstract][Full Text] [Related]
16. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
Radó JP; Marosi J; Fischer J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
[TBL] [Abstract][Full Text] [Related]
18. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
19. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
Moses AM; Moses LK; Notman DD; Springer J
J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
[TBL] [Abstract][Full Text] [Related]
20. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
Blackett PR; Seely JR; Altmiller DH; Males JL
Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]